• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates”.
    No. Publication Date Citing Article
    1 2024 Yuichi Nakahara, Tomoko Kawaguchi, Yutaka Matsuda, Yuta Endo, Masayo Date, Kazutoshi Takahashi, Keisuke Kato, Takahiro Okasora, Daisuke Ejima, Aiichiro Nagaki. Spatiotemporal Control of Protein Refolding through Flash-Change Reaction Conditions, Langmuir. 2024; 40: 8483.  https://doi.org/10.1021/acs.langmuir.4c00024
    2 2022 Yuichi Nakahara, Brian A. Mendelsohn, Yutaka Matsuda. Antibody–Drug Conjugate Synthesis Using Continuous Flow Microreactor Technology, Organic Process Research & Development. 2022; 26: 2766.  https://doi.org/10.1021/acs.oprd.2c00217
    3 2024 Shunsuke Yamazaki, Kazutoshi Takahashi, Yutaka Matsuda. Tag-free protein modification by lipoate ligase A: exploring substrate tolerance, Analytical Sciences. 2024; 40: 1111.  https://doi.org/10.1007/s44211-024-00534-6
    4 2024 Yuichi Nakahara, Yuta Endo, Monica Leung, Brian A. Mendelsohn, Yutaka Matsuda. Implementing an Efficient Technology Transfer for Biomolecule Production: A Case Study on Continuous-Mode Processes, Organic Process Research & Development. 2024; acs.oprd.4c00172.  https://doi.org/10.1021/acs.oprd.4c00172
    5 2023 Tomohiro Fujii, Kenichiro Ito, Kazutoshi Takahashi, Tsubasa Aoki, Rika Takasugi, Takuya Seki, Yusuke Iwai, Tomohiro Watanabe, Ryusuke Hirama, Ryo Tsumura, Hirobumi Fuchigami, Masahiro Yasunaga, Yutaka Matsuda. Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation, ACS Medicinal Chemistry Letters. 2023; 14: 1767.  https://doi.org/10.1021/acsmedchemlett.3c00414
    6 2023 Tomohiro Fujii, Yutaka Matsuda. Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry, Expert Opinion on Biological Therapy. 2023; 23: 1053.  https://doi.org/10.1080/14712598.2023.2276873
    7 2024 Swapnali Parit, Ajit Manchare, Amol D. Gholap, Prashant Mundhe, Navnath Hatvate, Satish Rojekar, Vandana Patravale. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy, International Journal of Pharmaceutics. 2024; 659: 124211124211.  https://doi.org/10.1016/j.ijpharm.2024.124211
    8 2023 Tomohiro Fujii, Yutaka Matsuda, Takuya Seki, Natsuki Shikida, Yusuke Iwai, Yuri Ooba, Kazutoshi Takahashi, Muneki Isokawa, Sayaka Kawaguchi, Noriko Hatada, Tomohiro Watanabe, Rika Takasugi, Akira Nakayama, Kazutaka Shimbo, Brian A. Mendelsohn, Tatsuya Okuzumi, Kei Yamada. AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production, Bioconjugate Chemistry. 2023; acs.bioconjchem.3c00040.  https://doi.org/10.1021/acs.bioconjchem.3c00040
    9 2024 Shunsuke Yamazaki, Kenichiro Ito, Tsubasa Aoki, Naoko Arashida, Tomohiro Watanabe, Tomohiro Fujii, Yutaka Matsuda. Biological Evaluation of Antibody-Drug Conjugates Produced by Tag-Free Lipoate Ligase A Modification, Biochemistry. 2024; 63: 644.  https://doi.org/10.1021/acs.biochem.3c00513
    10 2024 Tomohiro Watanabe, Naoko Arashida, Tomohiro Fujii, Natsuki Shikida, Kenichiro Ito, Kazutaka Shimbo, Takuya Seki, Yusuke Iwai, Ryusuke Hirama, Noriko Hatada, Akira Nakayama, Tatsuya Okuzumi, Yutaka Matsuda. Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug Conjugates, Journal of Medicinal Chemistry. 2024; 67: 18124.  https://doi.org/10.1021/acs.jmedchem.4c01251
    11 2023 Tomohiro Watanabe, Tomohiro Fujii, Jason T. Stofleth, Rika Takasugi, Kazutoshi Takahashi, Yutaka Matsuda. Scale-Up Synthesis of Site-Specific Antibody–Drug Conjugates Using AJICAP Second-Generation Technology, Organic Process Research & Development. 2023; 27: 1136.  https://doi.org/10.1021/acs.oprd.3c00111